 |
© Bulgarian Stock Exchange JSC |
Properties Capital investments REIT-Varna /PPO/ announces that the Executive Director of the company has discharged Silviya Dencheva Toncheva from the position of Investor Relations Director as of 01.10.2008 and has appointed Neli Vladimirova Ivanova an Investor Relations Director instead.
***
BSE-Sofia has received an application for listing of an issue of shares on the Unofficial market of Equities as follows:
- Issuer: MDCC "BIOCHECK" S.A.-Sofia
- ISIN: BG1100070066
- Amount of the issue: BGN 930,900
- Nominal value per share: BGN 1.00
- BSE code: M6D
***
Farin AD-Dobrich /9KDA/ submitted to X3 news a notification about the registration of a new company, Norex Energy OOD /UIC 200401290/, wherein Farin AD participates.
The entire notification is available on http://www.x3news.com.
***
BSE-Sofia has received an application for listing of an additional issue of shares as follows:
- Issuer: ZMM-Metalik Jsc-Pazardzhik /3ZD/
- ISIN of the issue: BG11ZMPAAT11
- Amount of the issue before the increase: BGN 201,000
- Amount of the increase: BGN 8,241,000
- Amount of the issue after the increase: BGN 8,442,000
- Nominal value per share: BGN 1.00
***
BSE-Sofia has received an application for listing of an additional issue of shares as follows:
- Issuer: Druzhba Staklarski Zavodi AD-Sofia /4DR/
- ISIN of the issue: BG11DRPLAT19
- Amount of the issue before the increase: BGN 6,689,562
- Amount of the increase: BGN 46,826,934
- Amount of the issue after the increase: BGN 53,516,496
- Nominal value per share: BGN 1.0
***
BSE-Sofia has received an application for listing of an additional issue of shares as follows:
- Issuer: Optela-Laser Technologies AD-Plovdiv /3OO/
- ISIN of the issue: BG11OPPLBT17
- Amount of the issue before the increase: BGN 315,000
- Amount of the increase: BGN 8,820,000
- Amount of the issue after the increase: BGN 9,135,000
- Nominal value per share: BGN 1.00
***
Sopharma AD-Sofia /3JR/ has submitted to X3 news Information concerning the financial results of September 2008 as follows:
Sopharma AD has registered a total growth of 46% in sales compared to the same month last year, which includes a growth of 105% in export sales and a drop of 31% in the sales on the domestic market.
The sales revenues from the first nine months of 2008 have increased by 10%, including an increase of the export by 26%.
The company has not registered a sales' growth on the domestic market mainly due to the reconstruction of the ampoule production as well as to the state of the pharmaceutical market in Bulgaria.
The entire notification is available at www.x3news.com.
***
With reference to Art. 47 (7) of Part IV to BSE Rules, BSE-Sofia informs all its members that the price ranges causing volatility interruptions shall be extended by 30% (thirty per cent).
*****
AII Data Processing does not endorse in any way, the views, opinions or recommendations expressed above. The use of the Information is subject to the terms and conditions as published by the original source, which you have to read and accept in full prior to the execution of any actions taken in reliance on Information contained herein.
 | SeeNews SeeNews is a business and financial news and information provider which brings its visitors and customers access to detailed coverage on the fast-growing companies, economies and markets of ten Southeast European nations. |
Search for: investments |
Search for: news |
Search for: market |
Search for: company |
Search for: sales |
Search for: Bulgaria |
